EPLUS (PLUS) director granted 1,478 restricted shares
Ira A. Hunt, a Director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of common stock on 10/01/2025 under the company's 2024 Non-Employee Director Long Term Incentive Plan.
Rhea-AI Filing Summary
Ira A. Hunt, a Director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of common stock on 10/01/2025 under the company's 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at a reported price of $0 and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest early under certain plan conditions or be forfeited.
Following the grant, Mr. Hunt beneficially owned 27,806 shares. The Form 4 was signed by the reporting person on 10/03/2025. The filing discloses the grant terms and the existence of the restriction period but contains no additional financial metrics, transaction consideration beyond the $0 reported price, or changes to prior holdings other than the post-grant ownership total.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,478 | $0.00 | $0.00 |
Footnotes (1)
- F1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ira A. Hunt report on the Form 4 for EPLUS (PLUS)?
What are the vesting or restriction terms disclosed?
What price was reported for the restricted stock award?
When was the Form 4 signed by the reporting person?
Does the filing disclose any derivative transactions or other security types?
AI-generated analysis. How Rhea-AI works. Not financial advice.